Search

Displaying results 6871 - 6880 of 10000 in total
  1. Drug

    Odatroltide

    go.drugbank.com/drugs/DB21511
    Experimental

    Odatroltide is a small molecule drug. Odatroltide has a monoisotopic molecular weight of 661.38 Da.

  2. Drug

    Sucunamostat

    go.drugbank.com/drugs/DB21523
    Experimental

    Sucunamostat is a small molecule drug. Sucunamostat has a monoisotopic molecular weight of 470.14 Da.

  3. Drug

    Paluratide

    go.drugbank.com/drugs/DB21694
    Investigational

    Paluratide is a small molecule drug. Paluratide has a monoisotopic molecular weight of 1436.79 Da.

  4. Drug

    Glasmacinal

    go.drugbank.com/drugs/DB21722
    Experimental

    Glasmacinal is a small molecule drug. Glasmacinal has a monoisotopic molecular weight of 694.44 Da.

  5. Drug

    Linustedastat

    go.drugbank.com/drugs/DB21729
    Experimental

    Linustedastat is a small molecule drug. Linustedastat has a monoisotopic molecular weight of 453.22 Da.

  6. Drug

    Polydioxanone

    go.drugbank.com/drugs/DB14832
    Investigational

    Polydioxanone is under investigation in clinical trial NCT00998907 (PDS*Plus and Wound Infections After Laparotomy).

    Synonyms: PDS II
  7. Drug

    Tarloxotinib

    go.drugbank.com/drugs/DB14944
    Investigational

    Tarloxotinib is under investigation in clinical trial NCT03743350 (NSCLC Exon 20 or HER2-activating Mutations).

  8. Drug

    LIS-1

    go.drugbank.com/drugs/DB18388
    Experimental

    LIS-1 is an immunoglobulin G (IgG) polyclonal antibody that binds to human T cells.

  9. Drug

    EXT608

    go.drugbank.com/drugs/DB18453
    Investigational

    EXT608 is a long-acting PTH derivative under investigation for the treatment of hyperparathyroidism.[L48270]

  10. Drug

    MUL001

    go.drugbank.com/drugs/DB18534
    Experimental

    MUL001 is live attenuated strain of _Salmonella typhimurium_ being investigated for the treatment of schwannomas.